Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Edelman strengthens healthcare team

Appoints Vicky Bramham, Louise Daltan and Emma Coughlan

- PMLiVE

Global Pricing Innovations and Partners4Access partner on market access

Will collaborate on orphan drug pricing and access solutions

- PMLiVE

Man Boobs campaign wins at D&AD Impact Awards

Takes home White Pencil in inaugural awards for creative contribution to society

- PMLiVE

Novartis says migraine prevention drug clears phase III trial

Monthly injection co-developed with Amgen could be launched in 2018

- PMLiVE

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Licenses two gene silencing programmes with up to $670m in the offing for the specialist

- PMLiVE

How merging firms can manage culture change

Addressing the potential problems and finding the solutions

- PMLiVE

Getting below the surface: regional and local market access

Gaining access to a national market is a key hurdle in a drug’s life cycle, as is getting through the maze of the different health technology assessments (HTAs) and pricing...

- PMLiVE

Nouscom appoints COO and board members

Dr Marina Udier Blagovic takes on newly-created role while three join board

- PMLiVE

Novo Nordisk to cut 1,000 jobs as diabetes competition builds

Cites intensifying US market in particular for move to reduce costs

Bayer symbol

Bayer and Merck take high-risk heart failure drug into phase III

Embarks on final study of vericiguat despite it not meeting objectives in phase II trial

- PMLiVE

Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal

Option to acquire the Austrian biotech after phase I trials remains open to Boehringer 

- PMLiVE

The global scourge of counterfeit medicines

Pharmaceuticals are a prime target for organised crime

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links